CSGP vs LYRA · P/E 484, rev $1.82B vs rev $1.5M
CoStar Group Inc (CSGP) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported CSGP revenue for 2026-06-30 was $1.82B. Net income was $58.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the CSGP and LYRA stock pages for the full models.
Not investment advice.